Therapeutic intervention with diuretics has historically been performed in an attempt to induce urine production and thus facilitate the filtration and excretion of metabolic wastes. Unfortunately these therapies are often ineffective and are not without risk of unwanted side effects. Fenoldopam (a selective dopamine DA-1 receptor agonist that induces renal vasodilation) has recently been shown to increase urine production in people with minimal side effects. Little is known regarding the effect of the drug on kidney filtration and whether there is potential for its use in dogs. The purpose of this study is to determine the effect of fenoldopam on kidney filtration by measuring glomerular filtration rate during fenoldopam administration. If fenoldopam increases filtration rate it may in turn facilitate removal of metabolic waste products, potentially leading to improved outcome in patients with AKI and decreased urine production.

AGSDCF Purpose

agsdcf_logo_smallThe American German Shepherd Dog Charitable Foundation, Inc. is a non-profit organization devoted to funding research projects that improve the health of the German Shepherd Dog.

We are grateful to the special dogs who have given their hearts and souls to make our daily lives happier. They ask nothing more than to be loved, fed, and their health needs met.

Your donations to this Foundation will help make future generations healthier and happier.



Contact us:

Welcome  |  What AGSDCF Does  |  How You Help  |  AGSDCF Organization  |  Links  |  Photos  |  Donations  |  Site Map

Copyright 2000-2017 by the American German Shepherd Dog Charitable Foundation, Inc.

RocketTheme Joomla Templates